BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 33706124)

  • 1. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
    Colling R; Bancroft H; Langman G; Soilleux E
    Virchows Arch; 2019 Feb; 474(2):187-192. PubMed ID: 30470932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid
    Al-Turkmani MR; Suriawinata MA; Deharvengt SJ; Green DC; Black CC; Shirai K; Dragnev KH; Tsongalis GJ
    Pract Lab Med; 2020 May; 20():e00156. PubMed ID: 32181314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
    Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
    BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples.
    Offerman S; Prinsen CF; Knol A; Methorst N; Kamphorst J; Niemantsverdriet M
    Diagn Pathol; 2021 Aug; 16(1):70. PubMed ID: 34344387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
    He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
    Behnke A; Cayre A; De Maglio G; Giannini G; Habran L; Tarsitano M; Chetta M; Cappellen D; Lespagnol A; Le Naoures C; Massazza G; Destro A; Bonzheim I; Rau A; Battmann A; Kah B; Watkin E; Hummel M
    Pathol Oncol Res; 2023; 29():1610707. PubMed ID: 36798672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
    Thomas De Montpréville V; Ghigna MR; Lacroix L; Lemoine A; Besse B; Mercier O; Fadel É; Dorfmuller P; Le Chevalier T;
    Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
    Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
    Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
    De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
    J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.
    Sousa AC; Silveira C; Janeiro A; Malveiro S; Oliveira AR; Felizardo M; Nogueira F; Teixeira E; Martins J; Carmo-Fonseca M
    Lung Cancer; 2020 Jan; 139():35-40. PubMed ID: 31715539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes.
    Haiduk T; Brockmann M; Tillmann RL; Pieper M; Lüsebrink J; Schildgen V; Schildgen O
    Exp Mol Pathol; 2021 Jun; 120():104634. PubMed ID: 33773991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR System.
    Heeke S; Hofman P
    Methods Mol Biol; 2019; 2054():147-155. PubMed ID: 31482454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
    Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid Idylla™ mutational testing: Current and future theranostic applications].
    Bourhis A; Remoué A; Samaison L; Uguen A
    Ann Pathol; 2022 Jul; 42(4):329-343. PubMed ID: 34991924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidics-based EGFR mutation detection and its implication in the resource-limited clinical setting.
    Joshi P; Gogte P; Pai T; Gurav M; Dhanawade D; Karnik N; Deshpande G; Kaushal R; Shetty O
    Int J Exp Pathol; 2024 Jun; 105(3):90-99. PubMed ID: 38717047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-rapid Idylla™
    Qiu T; Zhang F; Zheng B; Feng Z; Li W; Zeng H; Chu L; Ying J
    Front Oncol; 2023; 13():1064487. PubMed ID: 37064089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
    Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
    Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation Spectrum of
    Mao L; Zhao W; Li X; Zhang S; Zhou C; Zhou D; Ou X; Xu Y; Tang Y; Ou X; Hu C; Ding X; Luo P; Yu S
    Pathol Oncol Res; 2021; 27():602726. PubMed ID: 34257561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.